Abstract:Background Metastasis in breast cancer is a vital concern in treatment because most women with primary breast cancer have micrometastases to distant sites at diagnosis. As a member of the inhibitor of apoptosis protein (IAP) family, survivin has been proposed as an attractive target for new anticancer interventions. In this study, we investigated the role of the plasmid encoding the phosphorylation-defective mouse survivin threonine 34→alanine mutant (Msurvivin T34A plasmid) in suppressing both murine primary breast carcinomas and pulmonary metastases. Methods In vitro study, induction of apoptosis by Msurvivin T34A plasmid complexed with cationic liposome (DOTAP/Chol) was examined by PI staining fluorescence microscopy and flow cytometric analysis. The anti-tumor and anti-metastases activity of Msurvivin T34A plasmid complexed with cationic liposome (DOTAP/Chol) was evaluated in female BALB/c mice bearing 4T1 s.c. tumors. Mice were treated twice weekly with i.v. administration of Msurvivin T34A plasmid complexed with cationic liposome (DOTAP/Chol), PORF-9 null plasmid complexed with cationic liposome (DOTAP/Chol), 0.9% NaCl solution for 4 weeks. Tumor volume was observed. After sacrificed, tumor net weight was measured and Lung metastatic nodules of each group were counted. Assessment of apoptotic cells by TUNEL assay was conducted in tumor tissue. Microvessel density within tumor tissue was determined by CD31 immunohistochemistry. Alginate-encapsulated tumor cells test was conducted to evaluate the effect on angiogenesis. By experiment of cytotoxicity T lymphocytes, we test whether Msurvivin T34A plasmid complexed with cationic liposome (DOTAP/Chol) can induce specific cell immune response. Results Administration of Msurvivin T34A plasmid complexed with cationic liposome (DOTAP/Chol) resulted in significant inhibition in the growth and metastases of 4T1 tumor model. These anti-tumor and anti-metastases responses were associated with triggering the apoptosis of tumor cells directly, inhibiting angiogenesis and inducing specific cellular immune response. Conclusion The present findings suggest that the Msurvivin T34A plasmid complexed with cationic liposome may provide an effective approach to inhibit the growth and metastases of a highly metastatic mouse breast cancer model with minimal side effects.

Efficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34→Ala mutant

[Anti-Prostate Cancer Activity of Survivin-T34A Mutant in Vitro and in Vivo].

Inhibition of lymphatic metastases by a survivin dominant-negative mutant

Therapeutic effects of survivin dominant negative mutant in a mouse model of prostate cancer

Effects of Survivin Mrna Expression on Apoptosis and Proliferation and MDR-1 in Hepatocellular Carcinoma

Enhanced tumor radiosensitivity by a survivin dominant-negative mutant

Survivin Stable Knockdown by Sirna Inhibits Tumor Cell Growth and Angiogenesis in Breast and Cervical Cancers

The Ectopic Expression of Survivin T34A and FilC Can Enhance the Oncolytic Effects of Vaccinia Virus in Murine Gastric Cancer

Antitumor effects of MsurvivinT34A–CaPi complex-embedded PLGA nanoparticles in combination with Doxil in mice

Gene therapy for colon cancer by adeno-associated viral vector-mediated transfer of survivin Cys84Ala mutant

Inhibition of melanoma by survivin-specific lymphocytes combined with CCL17 and granulocyte-macrophage colony-stimulating factor in a mouse syngeneic model

Suppression Of Survivin Expression Inhibits In Vivo Tumorigenicity And Angiogenesis In Gastric Cancer

Effect on Apoptosis and Cell Cycle of Recombinant Double Negative Dominant Mutation Survivin (T34/117A) in Breast Cancer Cell B-Cap-37

Multisite mutation of monomer survivin with enhanced effect on apoptosis regulation of breast cancer cells.

Effect of Survivin-antisense on Liver Cancer Cell Line SMMC-7721 in Inducing Apoptosis and Increasing Its Sensitivity to Antineoplastic Agents

Rna Interference-Mediated Inhibition of Endogenous Survivin Expression in Hepatocarcinoma Cell

Suppression of tumor growth using a recombinant adenoviral vector carrying the dominant-negative mutant gene Survivin-D53A in a nude mice model

Enhancement of cisplatin sensitivity in Lewis Lung carcinoma by liposome-mediated delivery of a survivin mutant

Adeno-associated Virus-Mediated Survivin Mutant Thr34Ala Cooperates with Oxaliplatin to Inhibit Tumor Growth and Angiogenesis in Colon Cancer

Efficient Inhibition of Cisplatin-Resistant Human Ovarian Cancer Growth and Prolonged Survival by Gene Transferred Vesicular Stomatitis Virus Matrix Protein in Nude Mice

RETRACTED ARTICLE: Polyamidoamine Dendrimer Liposome-Mediated Survivin Antisense Oligonucleotide Inhibits Hepatic Cancer Cell Proliferation by Inducing Apoptosis